Ingrid Sollerer
General Counsel and Chief Compliance Officer, Executive Committee Member
Sandoz•Switzerland
View LinkedIn ProfileExecutive Overview
I joined Sandoz as a junior, temporary counsel in 1998. Along the way I've developed expertise across many different areas of the pharmaceutical industry, including business development and licensing, mergers and acquisitions, antitrust and competition law, litigation, arbitration, compliance, investigations, and much more. Today, as General Counsel and Chief Compliance Officer, I am proud to lead an outstanding, highly skilled, and business-oriented Legal and Compliance team spread around the globe, all working towards one common goal: pioneering access for patients. My team and I work hand-in-hand with every function at Sandoz to enable the development and delivery of generic and biosimilar medicines where they are needed most. We are profoundly committed to doing what is right, by equipping our associates to act with integrity and accountability, and by using our legal expertise and our strong voice to help shape the policies and frameworks that govern our industry, to the benefit of patients.
Career Timeline
- SandozCurrentFeb 2019–Present· 7 yrs 7 mos
- Chief Compliance Officer and General Counsel, Executive Committee MemberCurrentFeb 2019–Present
- Oct 2016–2019· 2 yrs 3 mos
- Global Head Legal Oncology Strategy and BD/Cell & GeneOct 2016–2019
- Oct 2012–Oct 2013· 1 yr
- Head Legal WEMEA/Global Anti-Infectives & RespiratoryOct 2012–Oct 2013
- 2007–Sep 2016· 9 yrs 8 mos
- Global Head Legal Biopharmaceuticals, Deputy General Counsel SandozFeb 2015–Sep 2016
- Global Head Legal Biopharmaceuticals, Oncology Injectables, Anti-Infectives and WEMEAOct 2013–2015
- Head Legal Western Europe, Middle East, Africa/Global Respiratory2007–Sep 2013
- Apr 2001–Sep 2007· 6 yrs 5 mos
- Senior Corporate Counsel M&A/Competition LawApr 2001–Sep 2007
- 2000–2000· 0 mos
- Legal Counsel2000–2000
- 2000–2000· 0 mos
- Legal Counsel2000–2000
- Mar 1998–Mar 2001· 3 yrs
- Legal CounselMar 1998–Mar 2001
Education
Healthcare System Excellence Program
Harvard T.H. Chan School of Public HealthFinance II
Harvard Business SchoolFinance
Harvard Business SchoolLaw
Universidad de SevillaDr. iur
Law
Universität Innsbruck